Mirae Asset Global ETFs Holdings’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$312K	Buy	90,109 +12,006	+15%	+$49.2K	﹤0.01%	2125
2025 Q4	$263K	Buy	78,103 +5,132	+7%	+$13.3K	﹤0.01%	2220
2025 Q3	$95.6K	Sell	72,971 -14,464	-17%	-$15K	﹤0.01%	2682
2025 Q2	$62.7K	Buy	87,435 +3,339	+4%	+$2.62K	﹤0.01%	2823
2025 Q1	$124K	Sell	84,096 -5,780	-6%	-$13.8K	﹤0.01%	2534
2024 Q4	$398K	Sell	89,876 -3,384	-4%	-$13.7K	﹤0.01%	2036
2024 Q3	$383K	Buy	93,260 +8,829	+10%	+$47.5K	﹤0.01%	2046
2024 Q2	$546K	Buy	+84,431	New	+$597K	﹤0.01%	1780

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mirae Asset Global ETFs Holdings's IRWD Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Ironwood Pharmaceuticals (IRWD) stake by 15% in Q1 2026, buying an estimated $49.2K and bringing the position to 90,109 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #2125.

Mirae Asset Global ETFs Holdings first reported a position in IRWD in Q2 2024 and has held it in 8 quarters since. The position peaked at $546K in Q2 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Mirae Asset Global ETFs Holdings held 90,109 shares of Ironwood Pharmaceuticals worth $312K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 12,006 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $49.2K.
Ironwood Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2125 holding.
Mirae Asset Global ETFs Holdings first reported a position in Ironwood Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Ironwood Pharmaceuticals position peaked at $546K in Q2 2024.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.